Data as of Dec 26
| -0.34 / -0.79%|
The 4 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 39.50, with a high estimate of 54.00 and a low estimate of 39.00. The median estimate represents a -7.45% decrease from the last price of 42.68.
The current consensus among 4 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.